Jubilant Ingrevia's Q1 FY 2026-27 Quarterly Results

Result Summary

• Jubilant Ingrevia Ltd reported a 10.3% quarter-on-quarter (QoQ) increase in its consolidated revenues for the quarter-ended Jun (Q1 FY 2026-27). On a year-on-year (YoY) basis, it witnessed a growth of 24.9%.
• Its expenses for the quarter were up by 8.7% QoQ and 23.2% YoY.
• The net profit increased 22.4% QoQ and increased 40.9% YoY.
• The earnings per share (EPS) of Jubilant Ingrevia Ltd stood at 6.68 during Q1 FY 2026-27.

Financial Statments for Q1 FY 2026-27

Data Source: BSE, Company announcements The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results

Company Overview

Jubilant Ingrevia Ltd is a prominent player in the chemical industry, primarily involved in manufacturing and supplying a wide range of specialty chemicals, nutrition and health solutions, and life science ingredients. The company operates within a sector that is crucial for various downstream industries like pharmaceuticals, agrochemicals, and consumer goods. Jubilant Ingrevia has consistently focused on innovation and sustainability, which are key drivers within the industry. As of the latest information available, the company is expanding its product portfolio and increasing its capacity to meet rising global demand. Any recent major developments beyond Q4 2023 are not available for this report.

Revenue

For Q1FY27, Jubilant Ingrevia Ltd reported total income of ₹1310.49 crores, reflecting a quarter-over-quarter (QoQ) increase of 10.3% from ₹1187.96 crores in Q4FY26. This also marked a significant year-over-year (YoY) growth of 24.9% compared to ₹1049.17 crores in Q1FY26. The consistent increase in revenue indicates robust demand for the company’s products and effective execution of its growth strategies. The revenue growth over the periods suggests an expansion in market share or an increase in sales volumes and pricing dynamics.

Profitability

The company’s profitability metrics showed considerable growth in Q1FY27. Profit Before Tax (PBT) was recorded at ₹140.89 crores, representing a 26.1% increase QoQ from ₹111.73 crores in Q4FY26 and a 41.1% YoY rise from ₹99.83 crores in Q1FY26. After accounting for taxes of ₹35.04 crores, the Profit After Tax (PAT) stood at ₹105.82 crores, up 22.4% QoQ from ₹86.44 crores and 40.9% YoY from ₹75.10 crores. The company’s Earnings Per Share (EPS) also increased to ₹6.68, up 23.9% QoQ from ₹5.39 and 40.6% YoY from ₹4.75, reflecting enhanced profitability and value generation for shareholders.

Operating Metrics

During Q1FY27, Jubilant Ingrevia Ltd managed its total expenses, which were ₹1169.60 crores, showing an 8.7% QoQ rise from ₹1076.23 crores and a 23.2% YoY increase from ₹949.34 crores. The rise in expenses aligned with revenue growth, indicating proportional scaling of operations. The tax expense of ₹35.04 crores in Q1FY27 increased by 38.7% QoQ from ₹25.27 crores and 42.0% YoY from ₹24.67 crores, consistent with higher profitability. The operating metrics reflect the company's ability to manage costs effectively while expanding its operational scale.